JP2025090864A5 - - Google Patents
Info
- Publication number
- JP2025090864A5 JP2025090864A5 JP2025049135A JP2025049135A JP2025090864A5 JP 2025090864 A5 JP2025090864 A5 JP 2025090864A5 JP 2025049135 A JP2025049135 A JP 2025049135A JP 2025049135 A JP2025049135 A JP 2025049135A JP 2025090864 A5 JP2025090864 A5 JP 2025090864A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- antibacterial
- intact
- tissue
- antibacterial pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762482630P | 2017-04-06 | 2017-04-06 | |
| US62/482,630 | 2017-04-06 | ||
| JP2019554855A JP2020513016A (ja) | 2017-04-06 | 2018-04-05 | 能力と安全性が増強された組成物および抗菌合成カチオン性ポリペプチド類を局所的に適用する使用 |
| PCT/US2018/026322 WO2018187617A1 (en) | 2017-04-06 | 2018-04-05 | Compositions and uses of locally applied antimicrobials with enhanced performance and safety |
| JP2023028902A JP7656643B2 (ja) | 2017-04-06 | 2023-02-27 | 能力と安全性が増強された組成物および抗菌合成カチオン性ポリペプチド類を局所的に適用する使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023028902A Division JP7656643B2 (ja) | 2017-04-06 | 2023-02-27 | 能力と安全性が増強された組成物および抗菌合成カチオン性ポリペプチド類を局所的に適用する使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025090864A JP2025090864A (ja) | 2025-06-17 |
| JP2025090864A5 true JP2025090864A5 (https=) | 2026-01-06 |
Family
ID=63712780
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019554855A Pending JP2020513016A (ja) | 2017-04-06 | 2018-04-05 | 能力と安全性が増強された組成物および抗菌合成カチオン性ポリペプチド類を局所的に適用する使用 |
| JP2023028902A Active JP7656643B2 (ja) | 2017-04-06 | 2023-02-27 | 能力と安全性が増強された組成物および抗菌合成カチオン性ポリペプチド類を局所的に適用する使用 |
| JP2025049135A Pending JP2025090864A (ja) | 2017-04-06 | 2025-03-24 | 能力と安全性が増強された組成物および抗菌合成カチオン性ポリペプチド類を局所的に適用する使用 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019554855A Pending JP2020513016A (ja) | 2017-04-06 | 2018-04-05 | 能力と安全性が増強された組成物および抗菌合成カチオン性ポリペプチド類を局所的に適用する使用 |
| JP2023028902A Active JP7656643B2 (ja) | 2017-04-06 | 2023-02-27 | 能力と安全性が増強された組成物および抗菌合成カチオン性ポリペプチド類を局所的に適用する使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US11285189B2 (https=) |
| EP (1) | EP3606543A4 (https=) |
| JP (3) | JP2020513016A (https=) |
| KR (2) | KR20240135875A (https=) |
| CN (1) | CN110740744A (https=) |
| AU (2) | AU2018249552A1 (https=) |
| BR (1) | BR112019020781A2 (https=) |
| CA (1) | CA3058901C (https=) |
| MX (2) | MX393548B (https=) |
| SG (1) | SG11201909016TA (https=) |
| WO (1) | WO2018187617A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102266659B1 (ko) | 2012-03-23 | 2021-06-17 | 아미크로베, 인코포레이티드. | 조직-적합성 특성을 갖는 항균물질의 조성물 및 용도 |
| CA3058901C (en) | 2017-04-06 | 2025-05-06 | Amicrobe, Inc. | Compositions and uses of topically applied antimicrobial agents offering improvements in performance and safety |
| JP2023501385A (ja) * | 2019-11-08 | 2023-01-18 | ユニバーシティ オブ ピッツバーグ － オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション | 抗微生物ペプチドを含む組成物 |
| CN115397454A (zh) * | 2020-03-31 | 2022-11-25 | 立美基股份有限公司 | 通过辐照对自组装肽进行灭菌 |
| KR20220166832A (ko) * | 2020-04-08 | 2022-12-19 | 아미크로베, 인코포레이티드. | 바이러스 감염의 예방 및 치료를 위한 국소 적용 합성 아미노산 중합체의 조성물 및 용도 |
| US12371463B2 (en) | 2021-04-20 | 2025-07-29 | University of Pittsburgh—of the Commonwealth System of Higher Education | Methods and compositions for treatment of antibiotic-resistant bacterial infections |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5636643A (en) | 1991-11-14 | 1997-06-10 | Wake Forest University | Wound treatment employing reduced pressure |
| US6632922B1 (en) | 1998-03-19 | 2003-10-14 | The Regents Of The University Of California | Methods and compositions for controlled polypeptide synthesis |
| US6680365B1 (en) | 1998-03-19 | 2004-01-20 | The Regents Of The University Of California | Methods and compositions for controlled polypeptide synthesis |
| US6686446B2 (en) | 1998-03-19 | 2004-02-03 | The Regents Of The University Of California | Methods and compositions for controlled polypeptide synthesis |
| TW570805B (en) | 1998-09-01 | 2004-01-11 | Hoffmann La Roche | Water-soluble pharmaceutical composition in an ionic complex |
| EP1156781B1 (en) | 1999-02-26 | 2005-06-08 | Chiron Corporation | Microemulsions with adsorbed macromolecules and microparticles |
| ES2260291T3 (es) | 2000-09-28 | 2006-11-01 | Chiron Corporation | Microparticulas para la administracion de acidos nucleicos heterologos. |
| US6835536B2 (en) | 2001-08-21 | 2004-12-28 | Micrologix Biotech Inc. | Antimicrobial cationic peptides and formulations thereof |
| WO2003020797A1 (en) | 2001-08-30 | 2003-03-13 | The Regents Of The University Of California | Transition metal initiators for controlled poly (beta-peptide) synthesis from beta-lactam monomers |
| JP2003171463A (ja) | 2001-12-06 | 2003-06-20 | Chisso Corp | ポリリジン及びその製造法 |
| CA2443472A1 (en) | 2002-02-07 | 2003-08-14 | Ophtecs Corporation | Liquid formulation for contact lenses |
| CA2509365C (en) | 2002-12-09 | 2012-08-07 | American Bioscience, Inc. | Compositions and methods of delivery of pharmacological agents |
| DE602004012269T2 (de) | 2003-07-11 | 2009-04-30 | Theravance, Inc., South San Francisco | Quervernetzte glycopeptid-cephalosporin-antibiotika |
| WO2005018701A1 (en) | 2003-08-25 | 2005-03-03 | Kane Biotech Inc. | Synergistic antimicrobial compositions and methods of inhibiting biofilm formation |
| WO2005063278A1 (en) | 2003-12-30 | 2005-07-14 | Bioactive Polymers Ab | Surface protection of exposed biological tissues |
| US20080145383A1 (en) | 2004-03-12 | 2008-06-19 | Intercell Ag | Method for Solubilizing Peptide Mixtures |
| EP1927597B1 (en) | 2004-08-18 | 2016-11-02 | Novabiotics Limited | Antibacterial peptides |
| CA2607841C (en) | 2005-06-06 | 2015-11-24 | Novozymes A/S | Polypeptides having antimicrobial activity and polynucleotides encoding same |
| US20080139450A1 (en) | 2005-07-01 | 2008-06-12 | Srinivasa Madhyastha | Antimicrobial Compositions and Uses Thereof |
| US20070190110A1 (en) | 2006-02-10 | 2007-08-16 | Pameijer Cornelis H | Agents and devices for providing blood clotting functions to wounds |
| CA2671461C (en) | 2006-12-01 | 2014-01-28 | The Regents Of The University Of California | Vesicles of self-assembling block copolymers and methods for making and using the same |
| CA2691645A1 (en) | 2007-06-25 | 2008-12-31 | Lipopeptide Ab | New medical products |
| EP2192923A2 (en) | 2007-08-27 | 2010-06-09 | Massachusetts Institute of Technology | Bi-functional polymer-attached inhibitors of influenza virus |
| CA2727428A1 (en) | 2008-06-19 | 2009-12-23 | Nippon Shinyaku Co., Ltd. | Drug carrier |
| CN102256613B (zh) | 2008-10-20 | 2014-09-10 | 莫伊莱麦屈克斯公司 | 用于治疗或者预防粘连的多肽 |
| WO2010083589A1 (en) | 2009-01-23 | 2010-07-29 | Kane Biotech Inc. | Biofilm-removing antimicrobial compositions and uses thereof |
| GB0905451D0 (en) | 2009-03-31 | 2009-05-13 | Novabiotics Ltd | Biofilms |
| EA037276B1 (ru) | 2010-04-27 | 2021-03-03 | Лисандо Аг | Способы устранения или уменьшения бактериальной биопленки |
| JP5902171B2 (ja) | 2010-08-23 | 2016-04-13 | ザ・リージェンツ・オブ・ザ・ユニバーシティー・オブ・カリフォルニアＴｈｅ Ｒｅｇｅｎｔｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃａｌｉｆｏｒｎｉａ | 高抗微生物活性および低毒性を有する材料の組成物および使用 |
| JP5613779B2 (ja) | 2011-01-19 | 2014-10-29 | 株式会社メニコン | コンタクトレンズ用液剤 |
| US9781949B2 (en) | 2011-03-31 | 2017-10-10 | The University Of Massachusetts | Antimicrobial delivery systems, methods of manufacture, and methods of use thereof |
| KR102266659B1 (ko) | 2012-03-23 | 2021-06-17 | 아미크로베, 인코포레이티드. | 조직-적합성 특성을 갖는 항균물질의 조성물 및 용도 |
| DE102014101663A1 (de) | 2014-02-11 | 2015-08-13 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Synthetische artifizielle Peptide mit antimikrobieller Wirkung |
| US10351599B2 (en) | 2014-09-19 | 2019-07-16 | Tensive Controls, Inc. | Anti-microbial peptides |
| AU2015338969B2 (en) * | 2014-10-30 | 2020-08-27 | Biomet Manufacturing, Llc | Methods of preventing surgical site infections |
| JP2016113373A (ja) * | 2014-12-11 | 2016-06-23 | エスポ化学株式会社 | 抗菌性、抗ウイルス性を有する水溶性組成物 |
| CA3058901C (en) | 2017-04-06 | 2025-05-06 | Amicrobe, Inc. | Compositions and uses of topically applied antimicrobial agents offering improvements in performance and safety |
| WO2019169324A1 (en) | 2018-03-02 | 2019-09-06 | January Therapeutics, Inc. | Nanoparticle compositions |
-
2018
- 2018-04-05 CA CA3058901A patent/CA3058901C/en active Active
- 2018-04-05 BR BR112019020781A patent/BR112019020781A2/pt unknown
- 2018-04-05 KR KR1020247029282A patent/KR20240135875A/ko not_active Ceased
- 2018-04-05 EP EP18780547.8A patent/EP3606543A4/en active Pending
- 2018-04-05 AU AU2018249552A patent/AU2018249552A1/en not_active Abandoned
- 2018-04-05 CN CN201880037998.9A patent/CN110740744A/zh active Pending
- 2018-04-05 WO PCT/US2018/026322 patent/WO2018187617A1/en not_active Ceased
- 2018-04-05 MX MX2019011912A patent/MX393548B/es unknown
- 2018-04-05 JP JP2019554855A patent/JP2020513016A/ja active Pending
- 2018-04-05 US US16/500,288 patent/US11285189B2/en active Active
- 2018-04-05 SG SG11201909016T patent/SG11201909016TA/en unknown
- 2018-04-05 KR KR1020197032623A patent/KR20200018400A/ko not_active Ceased
-
2019
- 2019-10-03 MX MX2022007904A patent/MX2022007904A/es unknown
-
2022
- 2022-03-08 US US17/654,021 patent/US12268722B2/en active Active
-
2023
- 2023-02-27 JP JP2023028902A patent/JP7656643B2/ja active Active
- 2023-04-13 AU AU2023202283A patent/AU2023202283A1/en active Pending
-
2025
- 2025-03-24 JP JP2025049135A patent/JP2025090864A/ja active Pending
- 2025-03-25 US US19/090,034 patent/US20260041728A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025090864A5 (https=) | ||
| ES2805225T3 (es) | Péptidos antimicrobianos y composiciones de los mismos | |
| ES2958621T3 (es) | Composiciones para el tratamiento tópico de infecciones microbianas | |
| CN104274490B (zh) | 包括银离子源和薄荷醇的抗菌组合物及其用途 | |
| JP2023054375A5 (https=) | ||
| JP5294876B2 (ja) | ハイドロゲル | |
| US20060240116A1 (en) | Bioactive factors in wound healing topical compositions and methods | |
| KR20140117379A (ko) | Dgla, 15-ohepa 및/또는 15-hetre를 포함하는 항미생물 조성물 및 그의 사용 방법 | |
| CN101325965B (zh) | 治疗粘膜破坏性炎症的转铁蛋白的应用 | |
| JP2020513016A5 (https=) | ||
| US8603542B2 (en) | Veterinary topical agent | |
| US9480669B2 (en) | Method of destroying and preventing bacterial and fungal biofilm by amino acid infusion | |
| CN1140266C (zh) | 二醇与α羟基酸的混合物在治疗角化过度性皮肤病中的用途 | |
| CN103347507A (zh) | 用于治疗痤疮的褪黑激素以及抗微生物剂或抗菌剂 | |
| JP2010505942A (ja) | 上皮細胞増殖因子を含有する安定な口内炎治療用液状組成物 | |
| JP2002212107A (ja) | 局所適用組成物 | |
| ITMI990449A1 (it) | Cerotto con spessore sottile contenente betametasone ed acido ialuronico per il trattamento di psoriasi dermatite dermatosi | |
| PT1374903E (pt) | Composições farmacêuticas para a prevenção do desenvolvimento e progressão de micoses cutâneas superficiais. | |
| ES2364269T3 (es) | Uso de derivado de amida de ge 2270 factor a3 para el tratamiento del acné. | |
| JP2018530622A (ja) | 尿路感染症を治療するための組成物および方法 | |
| US20220023244A1 (en) | Formulation for topical treatment of acute wounds | |
| RU2512757C1 (ru) | Антибактериальное и регенерирующее средство, выполненное в форме маслянистого геля для наружного применения | |
| US10438128B2 (en) | Treatment of autoimmune and inflammatory diseases with the arsenic compounds AS2O3 and/or AS2O5 administered locally | |
| JPH0782169A (ja) | 創傷治療剤 | |
| ITMI20091122A1 (it) | Formulazioni farmaceutiche per uso intravaginale nella prevenzione e terapia delle vulvo vaginiti e nel ripristino della fisiologia vaginale |